Advancing science together
At Fluicell, we do not just develop innovative tools for life science research, we also have a dedicated…
Fluicell welcomes Adina Lupu
Adina Lupu is joining Fluicell as Laboratory Assistant after completing her master’s degree in genomics and systems biology…
14
May
2020
Biopixlar webinar: liver model bioprinting
Biopixlar’s single-cell bioprinting capability is ideal for creating detailed in vitro tissue and disease models. In a live…
04
May
2020
THIS IS FLUICELL
“Fluicell started from a desire to push the bounds of science through inventiveness and ingenuity. For me, it…
21
Apr
2020
Fluicell’s response to COVID-19
As the COVID-19 infection spreads across the world, many workplaces struggle to keep activities going while minimizing exposure…
18
Mar
2020
First sale of Biopixlar and collaboration with University of Canterbury
We are proud to announce the first sale of the Biopixlar® platform to University of Canterbury, NZ. The…
03
Mar
2020
Promising new receptor modulator affecting cognitive dysfunction
The alpha-7 nicotinic receptor (nAChR) is an acetylcholine receptor with implied importance for long-term memory and with a…
03
Mar
2020
Biopixlar ready to face key challenges for bioprinting
As the world of bioprinting moves from concepts to actual biological applications, the performance requirements put on emerging…
13
Feb
2020
Fluicell at BPS 2020
Fluicell is an innovative biotech company with the ambition to create new opportunities for life science. This year,…
05
Feb
2020